These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2549202)
21. Evidence that ATP released from the postsynaptic site by noradrenaline, is involved in mechanical responses of guinea-pig vas deferens: cascade transmission. Vizi ES; Sperlágh B; Baranyi M Neuroscience; 1992 Sep; 50(2):455-65. PubMed ID: 1331864 [TBL] [Abstract][Full Text] [Related]
22. Effect of the dihydropyridine Bay K 8644 on the release of [3H]-noradrenaline from the rat isolated vas deferens. Ceña V; García AG; Khoyi MA; Salaices M; Sanchez-García P Br J Pharmacol; 1985 Jul; 85(3):691-6. PubMed ID: 2411327 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of alpha-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices. Pelayo F; Dubocovich ML; Langer SZ Eur J Pharmacol; 1980 Jun; 64(2-3):143-55. PubMed ID: 6249614 [TBL] [Abstract][Full Text] [Related]
24. Changes in electrophysiological properties and noradrenaline response in vas deferens of diabetic rats. Kamata K; Kirisawa H Eur J Pharmacol; 1998 Jun; 350(2-3):237-41. PubMed ID: 9696413 [TBL] [Abstract][Full Text] [Related]
25. Axonal transport of noradrenaline and noradrenergic transmission in rats with streptozotocin-induced diabetes. Tomlinson DR; Gillon KR; Smith MG Diabetologia; 1982 Mar; 22(3):199-204. PubMed ID: 6176490 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens. Sallés J; Badia A Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073 [TBL] [Abstract][Full Text] [Related]
27. Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors. Marshall I Br J Pharmacol; 1983 Jan; 78(1):221-31. PubMed ID: 6297648 [TBL] [Abstract][Full Text] [Related]
28. Effects of clorgyline on the release of noradrenaline from rat vas deferens. Ari G; Finberg JP Eur J Pharmacol; 1992 Aug; 219(1):89-96. PubMed ID: 1397052 [TBL] [Abstract][Full Text] [Related]
29. Investigations of prejunctional alpha 2-adrenoceptors in rat atrium, vas deferens and submandibular gland. Smith K; Connaughton S; Docherty JR Eur J Pharmacol; 1992 Feb; 211(2):251-6. PubMed ID: 1351849 [TBL] [Abstract][Full Text] [Related]
30. The effect of stimulus intensity on alpha-adrenoceptor-mediated feedback control of noradrenaline release. Harper B; Hughes IE Br J Pharmacol; 1978 Aug; 63(4):689-91. PubMed ID: 210875 [TBL] [Abstract][Full Text] [Related]
31. Peripheral noradrenergic function during chronic lithium treatment in the rat. Finberg JP; Kremer I; Spanir I; Lenox RH; Klein E J Neural Transm Gen Sect; 1992; 87(1):77-83. PubMed ID: 1311181 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens. Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370 [TBL] [Abstract][Full Text] [Related]
33. Release of [3H]-amezinium from cortical noradrenergic axons: a model for the study of the alpha-autoreceptor hypothesis. Hedler L; Starke K; Steppeler A Br J Pharmacol; 1983 Apr; 78(4):645-53. PubMed ID: 6303483 [TBL] [Abstract][Full Text] [Related]
34. The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Kenakin TP Br J Pharmacol; 1984 Jan; 81(1):131-41. PubMed ID: 6322891 [TBL] [Abstract][Full Text] [Related]
35. Role of adenylate cyclase in presynaptic alpha 2-adrenoceptor- and mu-opioid receptor-mediated inhibition of [3H]noradrenaline release from rat brain cortex slices. Schoffelmeer AN; Wierenga EA; Mulder AH J Neurochem; 1986 Jun; 46(6):1711-7. PubMed ID: 2422322 [TBL] [Abstract][Full Text] [Related]
36. Hyperreactivity of alpha 1-adrenoceptors, but not of P2X-purinoceptors, in vas deferens of spontaneously hypertensive rats. Katsuragi T; Kuratomi L; Sato C; Furukawa T Eur J Pharmacol; 1991 Jul; 199(3):303-7. PubMed ID: 1655481 [TBL] [Abstract][Full Text] [Related]
37. Calcium mobilization and phosphatidylinositol turnover in vas deferens smooth muscle of diabetic rats. Sakai Y; Aihara K; Honda H; Inazu M Eur J Pharmacol; 1989 Mar; 162(3):475-81. PubMed ID: 2744081 [TBL] [Abstract][Full Text] [Related]
38. Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens. Cleary L; Slattery J; Bexis S; Docherty JR Br J Pharmacol; 2004 Nov; 143(6):745-52. PubMed ID: 15451776 [TBL] [Abstract][Full Text] [Related]
39. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat. Eltze M; Boer R Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446 [TBL] [Abstract][Full Text] [Related]
40. Origin of ATP release in the rat vas deferens: concomitant measurement of [3H]noradrenaline and [14C]ATP. Vizi ES; Burnstock G Eur J Pharmacol; 1988 Dec; 158(1-2):69-77. PubMed ID: 2851460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]